2.775USD-1.42%Mkt Cap: 14.28M USDP/E: —Last update: 2026-06-01
MetaVia Inc., a clinical-stage biotechnology company, focuses on developing novel pharmaceuticals to treat cardiometabolic diseases. The company develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with devel…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap14.28M USD
Enterprise Value1.13M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-12.97M USD
Revenue/Share—
Last Price2.775 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.08
EV/Revenue—
P/S—
P/B1.23
EPS (TTM)-4.21
EPS (Forward)—
52W Range
0.966010% of range19.03
52W High19.03 USD
52W Low0.9660 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-243.26%
ROA-116.63%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.70M USD
CapEx (TTM)2.00K USD
FCF Margin—
FCF Yield-72.80%
Net Debt-13.54M USD
Net Debt/EBITDA0.98
Balance Sheet
Debt/Equity0.04
Current Ratio2.73
Quick Ratio2.65
Book Value/Sh2.310 USD
Cash/Share2.659 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 31, 2019
Splits
Last Split1:11
Split DateDec 5, 2025
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)19.33 USD
Target Range8.000 USD – 30.00 USD
# Analysts3
Ownership
Shares Out.5.16M
Float3.39M
Insiders34.50%
Institutions13.38%
Short Interest
Short Ratio0.5d
Short % Float2.04%
Short % Out.1.34%
Shares Short69.23K
Short (prev mo.)64.28K
Technical
SMA 501.579 (+75.8%)
SMA 2005.760 (-51.8%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)6.88M
Avg Vol (10d)20.31M
Technical Indicators
RSI (14)60.5
MACD0.4533
MACD Signal0.2896
MACD Hist.+0.1637
BB Upper3.791 USD
BB Middle1.919 USD
BB Lower0.0465 USD
BB Width195.15%
ATR (14)0.4733 USD
Vol Ratio (20d)0.09x